Trial
NCT02075047
Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolar I Disorder
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Collaborators
—
Condition
Bipolar Disorder
Intervention
placebo oral capsules
Why stopped
Based on recent input from FDA, the pre-specified final analysis will be performed at the current enrollment using a re-estimation of the sample size.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-06-16